Cyclic Peptides KS-133 and KS-487 Multifunctionalized Nanoparticles Enable Efficient Brain Targeting for Treating SchizophreniaKotaro Sakamoto, Eijiro Miyako, Tatsunori Miyaoka et al.|JACS Au|2024Cited by 11
An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in SchizophreniaKotaro Sakamoto, Yukio Ago, Zihao Jin et al.|Biological and Pharmaceutical Bulletin|2026Cited by 0